Publications by authors named "Andrey Strukov"
Introduction: Steroids and anti-IL6 biotherapy are highly effective in obtaining remission in patients with giant cell arteritis (GCA) but the risk of relapses remains high. We aimed to identify predictors of relapse in GCA.
Methods: All consecutive patients admitted with a new diagnosis of GCA - according to the 2022 American College of Rheumatology/EULAR (ACR/EULAR) classification criteria - between May 2011 and May 2022 were eligible for this study.
Background: Current guidelines for adult patients with pneumococcal meningitis (PM) recommend initial management in intermediate or intensive care units (ICU), but evidence to support these recommendations is limited. We aimed to describe ICU admission practices of patients with PM.
Methods: We conducted a retrospective analysis of the French medico administrative database of consecutive adult patients with PM and sepsis criteria hospitalized between 2011 and 2020.
Article Synopsis
- This study investigates the link between sepsis and the development of immune-mediated inflammatory diseases (IMIDs) in patients who survived sepsis, focusing on data from France in 2020.* -
- Researchers used a matched-cohort study design to compare the incidence of IMIDs in patients who had sepsis versus those who experienced acute myocardial infarction, finding a significantly higher risk of IMIDs in sepsis survivors.* -
- Results indicate an incidence rate of 7956 IMIDs per 100,000 patient-years after sepsis, with certain types of IMIDs, such as immune thrombocytopenia and autoimmune hemolytic anemia, showing particularly high risks.*
Objective: We analysed the incidence of, the specific outcomes and factors associated with COVID-19-associated organ failure (AOF) in patients with systemic lupus erythematosus (SLE) in France.
Methods: We performed a cohort study using the French national medical/administrative hospital database for the January 2011-November 2020 period. Each patient with SLE diagnosed in a French hospital with a COVID-19-AOF until November 2020 was randomly matched with five non-SLE patients with COVID-19-AOF.